Human Molecular Genetics, 2000, Vol. 9, No. 2 249-258
© 2000 Oxford University Press
Restrained chondrocyte proliferation and maturation with abnormal growth plate vascularization and ossification in human FGFR-3G380R transgenic mice
1Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 76100, Israel, 2ProChon Biotech Ltd, Kiryat Weizmann, Science Park, Rehovot 76114, Israel, 3Department of Clinical Biochemistry and 4Department of Oral Biology, Goldschleger School of Dental Medicine, Tel Aviv University, Ramat Aviv 69978, Israel
Achondroplasia, the most common genetic form of human dwarfism, results from a point mutation (G380R) in the gene for fibroblast growth factor receptor 3 (FGFR-3). Heterozygotes for the mutation share disproportionate, proximal shortening of the limbs, mid-face hypoplasia and relative macrocephaly due to a failure in endochondral ossification. Here we have generated transgenic mice expressing the human mutant FGFR-3 under the transcriptional control of the mouse gene. Mice that are hemizygous for the mutant human gene display disproportionate dwarfism with skeletal phenotypes remarkably similar to those of human achondroplasia. Mice that are homozygous for the transgene suffer from a profound delay in skeletal development and die at birth, similar in that respect to humans homozygous for the achondroplasia mutant gene. Microscopic analysis of long bones demonstrates growth plate morphology compatible with that of human achondroplasia cases, sharing endochondral growth inhibition with restrained chondrocyte proliferation and maturation, penetration of ossification tufts and aberrant vascularization.
+ To whom correspondence should be addressed. Tel: +972 8 9342696; Fax: +972 8 9344125; Email: liyayon@wiccmail.weizmann.ac.il
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
F. Sun, Q. Chen, S. Yang, Q. Pan, J. Ma, Y. Wan, C.-H. Chang, and A. Hong Remodeling of chromatin structure within the promoter is important for bmp-2-induced fgfr3 expression Nucleic Acids Res., July 1, 2009; 37(12): 3897 - 3911. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kolanczyk, N. Kossler, J. Kuhnisch, L. Lavitas, S. Stricker, U. Wilkening, I. Manjubala, P. Fratzl, R. Sporle, B. G. Herrmann, et al. Multiple roles for neurofibromin in skeletal development and growth Hum. Mol. Genet., April 15, 2007; 16(8): 874 - 886. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Hall, F. R. Westwood, and P. F. Wadsworth Review of the Effects of Anti-Angiogenic Compounds on the Epiphyseal Growth Plate Toxicol Pathol, February 1, 2006; 34(2): 131 - 147. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Bundschu, K.-P. Knobeloch, M. Ullrich, T. Schinke, M. Amling, C. M. Engelhardt, T. Renne, U. Walter, and K. Schuh Gene Disruption of Spred-2 Causes Dwarfism J. Biol. Chem., August 5, 2005; 280(31): 28572 - 28580. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Nowroozi, S. Raffioni, T. Wang, B. L. Apostol, R. A. Bradshaw, and L. M. Thompson Sustained ERK1/2 but not STAT1 or 3 activation is required for thanatophoric dysplasia phenotypes in PC12 cells Hum. Mol. Genet., June 1, 2005; 14(11): 1529 - 1538. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Sanchez and Y.-Z. He Daily or Intermittent Calcitriol Administration during Growth Hormone Therapy in Rats with Renal Failure and Advanced Secondary Hyperparathyroidism J. Am. Soc. Nephrol., April 1, 2005; 16(4): 929 - 938. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Murakami, G. Balmes, S. McKinney, Z. Zhang, D. Givol, and B. de Crombrugghe Constitutive activation of MEK1 in chondrocytes causes Stat1-independent achondroplasia-like dwarfism and rescues the Fgfr3-deficient mouse phenotype Genes & Dev., February 1, 2004; 18(3): 290 - 305. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nakajima, S. Shimizu, H. Moriya, and M. Yamazaki Expression of Fibroblast Growth Factor Receptor-3 (FGFR3), Signal Transducer and Activator of Transcription-1, and Cyclin-Dependent Kinase Inhibitor p21 during Endochondral Ossification: Differential Role of FGFR3 in Skeletal Development and Fracture Repair Endocrinology, October 1, 2003; 144(10): 4659 - 4668. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yu, J. Xu, Z. Liu, D. Sosic, J. Shao, E. N. Olson, D. A. Towler, and D. M. Ornitz Conditional inactivation of FGF receptor 2 reveals an essential role for FGF signaling in the regulation of osteoblast function and bone growth Development, July 1, 2003; 130(13): 3063 - 3074. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Cormier, A.-L. Delezoide, C. Benoist-Lasselin, L. Legeai-Mallet, J. Bonaventure, and C. Silve Parathyroid Hormone Receptor Type 1/Indian Hedgehog Expression Is Preserved in the Growth Plate of Human Fetuses Affected with Fibroblast Growth Factor Receptor Type 3 Activating Mutations Am. J. Pathol., October 1, 2002; 161(4): 1325 - 1335. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Ornitz and P. J. Marie FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease Genes & Dev., June 15, 2002; 16(12): 1446 - 1465. [Full Text] [PDF] |
||||
![]() |
A. Hoffmann, S. Czichos, C. Kaps, D. Bachner, H. Mayer, Y. Zilberman, G. Turgeman, G. Pelled, G. Gross, and D. Gazit The T-box transcription factor Brachyury mediates cartilage development in mesenchymal stem cell line C3H10T1/2 J. Cell Sci., February 15, 2002; 115(4): 769 - 781. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Rozenblatt-Rosen, E. Mosonego-Ornan, E. Sadot, L. Madar-Shapiro, Y. Sheinin, D. Ginsberg, and A. Yayon Induction of chondrocyte growth arrest by FGF: transcriptional and cytoskeletal alterations J. Cell Sci., January 2, 2002; 115(3): 553 - 562. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Iwata, C.-L. Li, C.-X. Deng, and C. A. Francomano Highly activated Fgfr3 with the K644M mutation causes prolonged survival in severe dwarf mice Hum. Mol. Genet., June 1, 2001; 10(12): 1255 - 1264. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sahni, R. Raz, J. D. Coffin, D. Levy, and C. Basilico STAT1 mediates the increased apoptosis and reduced chondrocyte proliferation in mice overexpressing FGF2 Development, June 1, 2001; 128(11): 2119 - 2129. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Chen, C. Li, W. Qiao, X. Xu, and C. Deng A Ser365{->}Cys mutation of fibroblast growth factor receptor 3 in mouse downregulates Ihh/PTHrP signals and causes severe achondroplasia Hum. Mol. Genet., March 1, 2001; 10(5): 457 - 465. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Iwata, L. Chen, C.-l. Li, D. A. Ovchinnikov, R. R. Behringer, C. A. Francomano, and C.-X. Deng A neonatal lethal mutation in FGFR3 uncouples proliferation and differentiation of growth plate chondrocytes in embryos Hum. Mol. Genet., July 1, 2000; 9(11): 1603 - 1613. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Aikawa, G. V. Segre, and K. Lee Fibroblast Growth Factor Inhibits Chondrocytic Growth through Induction of p21 and Subsequent Inactivation of Cyclin E-Cdk2 J. Biol. Chem., July 27, 2001; 276(31): 29347 - 29352. [Abstract] [Full Text] [PDF] |
||||









